The Embryo Health Score® Test evaluates genetic variants associated with common polygenic conditions — offering additional biological context when prioritizing embryos for transfer.
LifeView offers a complete portfolio of PGT: PGT-A for aneuploidy, PGT-A+ identifying parental origin of chromosomal abnormalities, PGT-M for monogenic disease, PGT-SR for structural rearrangements, M2 testing miscarriage risk, Embryo Health Score® for polygenic disease risk
@GenomPrediction LifeView’s PGT data helps clinics guide patients in choosing healthy embryos.
Reducing genetic disease risk can make all the difference in family building.
Supporting clinical expertise with advanced genomics #PGT#Genetics
💬 Ready to bring deeper genetic insights into your clinic’s IVF care?
📩 Connect with our team at [email protected] to learn more about adding LifeView to your service offerings.
From PGT-A to PGT-A+, PGT-M, PGT-SR, and the unique Embryo Health Score test, LifeView empowers clinicians with a full suite of tools to support patient-centered decisions.
Hanukkah celebrates light, resilience, and faith that even a small spark can carry us through uncertainty. For families building their future, the path isn’t linear—it takes patience, hope, science, and courage, one step at a time. Wishing peace and light to all who celebrate.
@dr_appie Statistical studies of the current population have shown that healthier individuals often enjoy other positive aspects of life. These studies do not determine what is the cause or the effect but only show a connection between the two.
I talked to @hsu_steve of Genomic Prediction about the present and future of reproductive technology. Lots to digest. Def worth a listen https://t.co/26SG6DLjZN
The goal of genetic counseling is to ensure that patients are equipped with knowledge about the benefits, risks, and limitations of PGT, as well as any relevant clinical policies, to make informed testing decisions. #IVF#GenomicPrediction#LifeView#GeneticTesting